Since two month, NRI shares on toronto market (Nuvo Research) have really progress. 2012 will be a great year for this company. After trade to 0,05 $, the shares are now to 0,125 $. more than 100 % of profit. Reason of this progression is the voltaren problem with her gel. NRI have profit of thi problem of increase her sales. In april 16, the FDA will show if the pensaid will be aprouved. To may month, the company will show the result of the first quarter of 2012. Results must be the best result of the society because in the report of the last quarter 2011, the company show a great increase in sales because voltaren problem. 2 Greats news should do increase the shares of the society and with the great numbers of insider transaction, they are not douth than the 2 first quarter of the company will be good.
Give me your opinion.
